Sarah E. Musulin
Clinical Associate Professor, Emergency & Critical Care
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Objective To evaluate the major crossmatch compatibility between rabbit recipients, rabbit donors, and the major canine and feline blood types. Design Prospective in vitro study in December 2021. Setting Academic veterinary teaching hospital. Animals Whole blood samples were collected from 11 healthy New Zealand White rabbits ( Oryctolagus cuniculus ) with no previous transfusion history. Three pigtail segments were acquired from dog erythrocyte antigen (DEA)‐1‐positive, DEA‐1‐negative, and feline type A blood units. Whole blood was collected from a healthy type B blood donor cat. Interventions Blood from each rabbit recipient underwent a major crossmatch using standard tube crossmatch methodology with itself and the following donor blood types: rabbit, DEA‐1‐positive, DEA‐1‐negative, feline type A, and feline type B. Measurements and Main Results Self‐crossmatches and crossmatches between rabbit recipients and conspecific donors were negative for hemolysis and agglutination. Crossmatches between rabbit recipients and canine and feline donors yielded no hemolysis but produced varying degrees of macroscopic and microscopic agglutination. Rabbit recipients had 1.4 (95% confidence interval: 1.1–1.8) times the risk of macroscopic agglutination when major crossmatched with canine blood compared to feline blood. No significant difference in agglutination was found between DEA‐1‐positive and DEA‐1‐negative or feline type A and type B donors. Conclusions These findings support allogeneic blood transfusions between rabbits being highly compatible and suggest rabbits have naturally occurring alloantibodies against both canine and feline red blood cells. However, feline red blood cells had a lower rate of in vitro incompatibility on major crossmatch, suggesting potentially higher in vivo compatibility if an emergency xenotransfusion is needed. Further prospective research is needed to determine if xenotransfusion is associated with a higher incidence of acute and delayed transfusion reactions in rabbits than allogeneic transfusions.
Year:
2024
Objective To evaluate the safety of repeated administration of a lyophilized canine‐specific albumin (CSA) product and to quantify its effect on serum albumin concentrations and colloid osmotic pressure (COP) in healthy dogs. Design Prospective study. Setting University research facility. Animals Six healthy, adult, purpose‐bred Beagles. Interventions Dogs received 1 g/kg of 16% CSA intravenously on days 1, 2, and 14 and were observed, with serial measurement of vital parameters during and for 2 hours after each infusion, to monitor for adverse events or evidence of a hypersensitivity reaction. Serum albumin concentration and COP were measured at predetermined time points before and after each infusion. Results One dog experienced a single episode of vomiting approximately 1 hour after completion of the second infusion. No other adverse reactions were observed during the 28‐day study period. Serum albumin concentration was increased by a mean of 0.57 g/dL (5.7 g/L) ( P = 0.003) when measured 2 hours after the first CSA infusion, and albumin concentration remained significantly higher than baseline at 24 hours after infusion, with a mean difference of 0.42 g/dL (4.2 g/dL) ( P < 0.001). The second and third CSA infusions similarly increased serum albumin concentration at 2 hours ( P = 0.001 and P = 0.001, respectively) and 24 hours ( P = 0.012 and P = 0.007, respectively) after infusion. COP increased by a mean of 2.03 mm Hg at 2 hours after the first infusion ( P = 0.013) and remained significantly higher than baseline at 24 hours after infusion, with a mean difference of 1.52 mm Hg ( P = 0.002). The second CSA infusion similarly increased COP at 2 hours ( P < 0.001) and 24 hours ( P = 0.017) after infusion. The third CSA infusion increased COP at 2 hours after infusion ( P = 0.004) but did not achieve statistical significance at 24 hours after infusion ( P = 0.053). Conclusions A 1‐g/kg dose of lyophilized CSA was effective at increasing serum albumin concentration and COP. Repeated infusions of CSA appear safe in healthy dogs.
Year:
2024
Collaborators (1)
Sarah Ozawa
Clinical Assistant Professor
College of Veterinary Medicine, North Carolina State University
Make your next move.
Prepare your application
Review drafts before you send them.